Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,500.00    -25.00 (-0.45%)
Bid:
5,500.00
Ask:
5,550.00
Spread: 50.00 (0.909%)
Market Cap: £139.03m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

BF&M Strategic Review Conclusion

30 Jan 2023 07:00

RNS Number : 1765O
Camellia PLC
30 January 2023
 

30 January 2023

Camellia Plc

 

(the "Company" or the "Group")

 

Associate Company Update

 

Camellia Plc (CAM.L) notes that its 36.9% owned associate company, BF&M Limited ("BF&M"), a listed Bermudian insurance business, has issued a statement that it has concluded its previously announced strategic review. The BF&M Board has determined that continuing to execute its strategic plan on a standalone basis is in the best interest of all BF&M shareholders, that BF&M remains in a strong capital position, has the right strategic plan already in place and a foundation for growth. BF&M remains focussed on taking decisive steps to create value for its shareholders. The full text of BF&M's announcement can be found in Appendix 1 to this announcement.

 

 

Enquiries

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

Maitland/AMO

PR

William Clutterbuck 07785 292617

 

 

 

  

Appendix 1

BF&M Concludes Strategic Review

 

Hamilton, Bermuda, 7 December 2022 - BF&M Limited ("BF&M", "the BF&M Group" or "the Company") today announced that its Board of Directors (the "Board") concluded its previously announced review of strategic alternatives (the "Strategic Review"). After a comprehensive process with the assistance of Desjardins Capital Markets, the Board has determined that continuing to execute its strategic plan on a standalone basis is in the best interest of all shareholders.

 

Anthony Joaquin, Acting Chairman of the Board, said, "During our review, the Board assessed a comprehensive range of potential outcomes. Ultimately, this process reinforced our confidence that BF&M has the right strategic plan already in place to maximize value for shareholders. With this evaluation concluded, the Board is fully committed to supporting Abigail and the rest of the Company's leadership team as they continue to execute this plan."

 

Abigail Clifford, Chief Executive Officer, said, "BF&M is entering 2023 with a strong capital position and foundation for growth, including the highest AM Best financial strength rating of any domestic insurers operating in Bermuda and the Caribbean. We remain focused on taking decisive steps to create value for shareholders, while providing best-in-class support to our clients as they navigate a challenging economic environment and positioning BF&M as an employer of choice."

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBKLLLXFLFBBF
Date   Source Headline
6th May 20104:06 pmRNSAnnual Financial Report
29th Apr 20103:04 pmRNSAnnual Financial Report
15th Apr 20102:08 pmRNSDisposal
1st Apr 201011:10 amRNSAppointment of Joint Managing Directors
26th Mar 201010:30 amRNSDirectorate Change
25th Mar 201011:59 amRNSInterim Management Statement
8th Mar 20107:00 amRNSDisposal
5th Mar 20107:00 amRNSStatement Re Siegfried Holding AG
28th Oct 20093:20 pmRNSInterim Management Statement
13th Oct 200910:06 amRNSCircular regarding change of auditor
14th Sep 20094:00 pmRNSDisposal
8th Sep 200910:44 amRNSHalf Yearly Report
27th Aug 200911:00 amRNSHalf Yearly Report
29th Jun 20094:40 pmRNSSecond Price Monitoring Extn
29th Jun 20094:35 pmRNSPrice Monitoring Extension
10th Jun 20094:40 pmRNSSecond Price Monitoring Extn
10th Jun 20094:35 pmRNSPrice Monitoring Extension
4th Jun 20091:40 pmRNSResult of AGM
3rd Jun 20094:40 pmRNSSecond Price Monitoring Extn
3rd Jun 20094:35 pmRNSPrice Monitoring Extension
3rd Jun 200912:12 pmRNSAGM Statement
29th May 20092:55 pmRNSAnnual Information Update
6th May 20092:00 pmRNSAnnual Report and Accounts
28th Apr 20096:26 pmRNSAnnual Financial Report
26th Mar 20092:20 pmRNSInterim Management Statement
2nd Feb 20094:35 pmRNSPrice Monitoring Extension
3rd Dec 20082:23 pmRNSDirector/PDMR Shareholding
24th Nov 20083:37 pmRNSHolding(s) in Company
21st Oct 20084:44 pmRNSSecond Price Monitoring Extn
21st Oct 20084:37 pmRNSPrice Monitoring Extension
2nd Oct 20082:30 pmRNSInterim Management Statement
29th Sep 20082:02 pmRNSDirectorate Change
17th Sep 20083:08 pmRNSInterim Report
28th Aug 20083:29 pmRNSInterim Results
6th Jun 200812:52 pmRNSResult of AGM
5th Jun 200812:13 pmRNSAGM Statement
30th May 20082:41 pmRNSAnnual Information Update
21st May 200811:49 amRNSDirector/PDMR Shareholding
13th May 20083:41 pmRNSDirector/PDMR Shareholding
8th May 20084:04 pmRNSDirector/PDMR Shareholding
2nd May 200812:19 pmRNSAnnual Report and Accounts
29th Apr 20084:12 pmRNSDirector/PDMR Shareholding
24th Apr 200812:35 pmRNSPreliminary announcement
27th Mar 20083:09 pmRNSInterim Management Statement
4th Oct 20073:16 pmRNSInterim Report
27th Sep 200712:30 pmRNSInterim Results
9th Aug 20074:24 pmRNSHolding(s) in Company
8th Jun 20074:06 pmRNSResult of AGM
7th Jun 200712:15 pmRNSAGM Statement
1st Jun 20073:01 pmRNSAnnual Information Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.